{"id":64284,"date":"2026-04-30T13:51:23","date_gmt":"2026-04-30T05:51:23","guid":{"rendered":"https:\/\/flcube.com\/?p=64284"},"modified":"2026-04-30T13:51:23","modified_gmt":"2026-04-30T05:51:23","slug":"suzhou-basecare-medical-secures-chinas-first-nmpa-approval-for-thalassemia-preimplantation-genetic-testing-kit","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=64284","title":{"rendered":"Suzhou Basecare Medical Secures China&#8217;s First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit"},"content":{"rendered":"\n<p><strong>Suzhou Basecare Medical Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/2170:HKG\">HKG: 2170<\/a>) announced that China&#8217;s <strong>National Medical Products Administration (NMPA)<\/strong> has granted <strong>Category III medical device approval<\/strong> for its <strong>preimplantation genetic testing for thalassemia kit (semiconductor sequencing method)<\/strong>, marking the <strong>first such PGT-M kit approved specifically for thalassemia<\/strong> in China.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-milestone\">Regulatory Milestone<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Agency<\/strong><\/td><td>NMPA (China)<\/td><\/tr><tr><td><strong>Approval Type<\/strong><\/td><td>Category III medical device (highest risk classification)<\/td><\/tr><tr><td><strong>Product<\/strong><\/td><td>Preimplantation genetic testing for thalassemia kit (semiconductor sequencing method)<\/td><\/tr><tr><td><strong>Indication<\/strong><\/td><td>Qualitative detection of blastocyst trophoblast cells from in vitro cultured embryos for thalassemia mutation analysis<\/td><\/tr><tr><td><strong>Approval Significance<\/strong><\/td><td>First PGT-M kit specifically approved for thalassemia in China<\/td><\/tr><tr><td><strong>Market Gap Addressed<\/strong><\/td><td>Fills domestic void in preimplantation genetic testing for monogenic disorders<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-technology-profile-amp-clinical-application\">Technology Profile &amp; Clinical Application<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Methodology:<\/strong> Semiconductor sequencing-based genetic analysis<\/li>\n\n\n\n<li><strong>Target Condition:<\/strong> <strong>Thalassemia<\/strong> \u2013 an autosomal recessive hereditary blood disorder caused by globin gene defects<\/li>\n\n\n\n<li><strong>Sample Requirements:<\/strong> Blastocyst trophoblast cells from embryos + genomic DNA from both parents and\/or relevant relatives<\/li>\n\n\n\n<li><strong>Analytical Approach:<\/strong> Genetic linkage analysis to determine whether embryos have inherited parental thalassemia mutations<\/li>\n\n\n\n<li><strong>Clinical Utility:<\/strong> Enables physicians to select genetically suitable embryos for implantation, preventing thalassemia transmission to offspring<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-public-health-impact\">Market Context &amp; Public Health Impact<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Aspect<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Disease Burden<\/strong><\/td><td>Thalassemia affects approximately 30 million carriers in China, with high prevalence in southern provinces<\/td><\/tr><tr><td><strong>Current Limitations<\/strong><\/td><td>Previously limited access to specialized PGT-M services for monogenic disorders, often requiring overseas testing<\/td><\/tr><tr><td><strong>Regulatory Landscape<\/strong><\/td><td>Category III approval represents stringent safety and efficacy requirements for high-risk medical devices<\/td><\/tr><tr><td><strong>Healthcare Integration<\/strong><\/td><td>Kit enables domestic IVF centers to offer comprehensive genetic screening without international referrals<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-commercial-outlook-amp-strategic-implications\">Commercial Outlook &amp; Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Leadership:<\/strong> Basecare establishes first-mover advantage in China&#8217;s emerging PGT-M market for monogenic disorders<\/li>\n\n\n\n<li><strong>Expansion Potential:<\/strong> Platform technology could be adapted for other single-gene disorders, creating a pipeline of PGT-M kits<\/li>\n\n\n\n<li><strong>Healthcare Accessibility:<\/strong> Domestic approval significantly reduces cost and turnaround time compared to international testing options<\/li>\n\n\n\n<li><strong>Reproductive Medicine Advancement:<\/strong> Supports China&#8217;s broader initiative to improve genetic disease prevention and reproductive health outcomes<\/li>\n\n\n\n<li><strong>Competitive Moat:<\/strong> Semiconductor sequencing methodology may offer cost and speed advantages over traditional next-generation sequencing approaches<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding market adoption, regulatory pathways, and commercial expectations for Basecare&#8217;s PGT-M kit. Actual results may differ due to risks including market penetration rates, competitive developments, and evolving regulatory requirements.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/2026042904119_c.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 2026042904119_c.\"><\/object><a id=\"wp-block-file--media-f822694f-6893-4129-8ae3-ae83da4064b2\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/2026042904119_c.pdf\">2026042904119_c<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/2026042904119_c.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-f822694f-6893-4129-8ae3-ae83da4064b2\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Suzhou Basecare Medical Co., Ltd. (HKG: 2170) announced that China&#8217;s National Medical Products Administration (NMPA)&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[1906,1907,15],"class_list":["post-64284","post","type-post","status-publish","format-standard","hentry","category-company","category-medical-device","tag-basecare-medical","tag-hkg-2170","tag-product-approvals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Suzhou Basecare Medical Secures China&#039;s First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Suzhou Basecare Medical Co., Ltd. (HKG: 2170) announced that China&#039;s National Medical Products Administration (NMPA) has granted Category III medical device approval for its preimplantation genetic testing for thalassemia kit (semiconductor sequencing method), marking the first such PGT-M kit approved specifically for thalassemia in China.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=64284\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Suzhou Basecare Medical Secures China&#039;s First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit\" \/>\n<meta property=\"og:description\" content=\"Suzhou Basecare Medical Co., Ltd. (HKG: 2170) announced that China&#039;s National Medical Products Administration (NMPA) has granted Category III medical device approval for its preimplantation genetic testing for thalassemia kit (semiconductor sequencing method), marking the first such PGT-M kit approved specifically for thalassemia in China.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=64284\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-30T05:51:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64284#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64284\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Suzhou Basecare Medical Secures China&#8217;s First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit\",\"datePublished\":\"2026-04-30T05:51:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64284\"},\"wordCount\":394,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Basecare Medical\",\"HKG: 2170\",\"Product approvals\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=64284#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64284\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=64284\",\"name\":\"Suzhou Basecare Medical Secures China's First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-30T05:51:23+00:00\",\"description\":\"Suzhou Basecare Medical Co., Ltd. (HKG: 2170) announced that China's National Medical Products Administration (NMPA) has granted Category III medical device approval for its preimplantation genetic testing for thalassemia kit (semiconductor sequencing method), marking the first such PGT-M kit approved specifically for thalassemia in China.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64284#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=64284\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64284#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Suzhou Basecare Medical Secures China&#8217;s First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Suzhou Basecare Medical Secures China's First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit - Insight, China&#039;s Pharmaceutical Industry","description":"Suzhou Basecare Medical Co., Ltd. (HKG: 2170) announced that China's National Medical Products Administration (NMPA) has granted Category III medical device approval for its preimplantation genetic testing for thalassemia kit (semiconductor sequencing method), marking the first such PGT-M kit approved specifically for thalassemia in China.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=64284","og_locale":"en_US","og_type":"article","og_title":"Suzhou Basecare Medical Secures China's First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit","og_description":"Suzhou Basecare Medical Co., Ltd. (HKG: 2170) announced that China's National Medical Products Administration (NMPA) has granted Category III medical device approval for its preimplantation genetic testing for thalassemia kit (semiconductor sequencing method), marking the first such PGT-M kit approved specifically for thalassemia in China.","og_url":"https:\/\/flcube.com\/?p=64284","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-30T05:51:23+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=64284#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=64284"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Suzhou Basecare Medical Secures China&#8217;s First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit","datePublished":"2026-04-30T05:51:23+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=64284"},"wordCount":394,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Basecare Medical","HKG: 2170","Product approvals"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=64284#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=64284","url":"https:\/\/flcube.com\/?p=64284","name":"Suzhou Basecare Medical Secures China's First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-30T05:51:23+00:00","description":"Suzhou Basecare Medical Co., Ltd. (HKG: 2170) announced that China's National Medical Products Administration (NMPA) has granted Category III medical device approval for its preimplantation genetic testing for thalassemia kit (semiconductor sequencing method), marking the first such PGT-M kit approved specifically for thalassemia in China.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=64284#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=64284"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=64284#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Suzhou Basecare Medical Secures China&#8217;s First NMPA Approval for Thalassemia Preimplantation Genetic Testing Kit"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=64284"}],"version-history":[{"count":2,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64284\/revisions"}],"predecessor-version":[{"id":64287,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64284\/revisions\/64287"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=64284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=64284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=64284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}